Setting a new standard
An advanced FFR pressure guidewire with fiber optic sensing technology.
An advanced FFR pressure guidewire with fiber optic sensing technology.
Experience an entirely new level of productivity with OptoWire. The first Nitinol based FFR pressure guidewire with fiber optic sensing technology.
Easy cathlab integration and intuitive workflow. OptoMonitor offers an intuitive step-by-step workflow with state of the art touch screen.
A valid question. Is PCI necessary and beneficial for patient with a coronary stenosis without evidence of ischemia?
More details Read more about DEFER study and the 5-year follow-upImproved outcomes. Using fractional flow reserve (FFR) measurements during stenting procedures reduced MACE by 28% and a strong trend towards a lower rate of death, MI or the need for repeat revascularization in the FFR guided approach.
More details Read more about DEFER study and the 5-year follow-upBetter patient outcomes with FFR-Guided cardiac stenting. The use of FFR-guided PCI led to an 86 % decrease in risk of unplanned hospitalization for urgent revascularization, compared with medical treatment alone.
More details Read more about DEFER study and the 5-year follow-upExperience an entirely new level of productivity with: our FFR products
Established in 2003, Opsens Medical, a division of Opsens (TSX:OPS) was founded on the belief that our innovative technologies will help to improve cardiovascular disease treatment.
Our ground-breaking solutions are designed to improve your success rate in the most challenging peripheral and coronary interventions. We combine the most innovative and reliable fiber optic sensing technology with advanced guidewire materials construction so that you can accomplish more in less procedure time and with lower overall cost.
Our goal is the same as yours: better outcomes.